‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
Formycon CEO Talks Candidate Selection Strategy And Recent Biosimilar Regulatory Changes
A number of factors play into Formycon’s portfolio selection strategy • Source: Shutterstock 
